Home / Market Reports / Medical Devices & Consumables
/ Global Implantable Neurostimulation Devices Market Growth 2024-2030
Global Implantable Neurostimulation Devices Market Growth 2024-2030
Product Code:1246542
Published Date: Dec 24,2024
Pages: 99
Region: Global
Category: Medical Devices & Consumables
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
Provide comprehensive and accurate analysis and reports according to your exact requirements
The global Implantable Neurostimulation Devices market size is predicted to grow from US$ 5856 million in 2024 to US$ 10710 million in 2030; it is expected to grow at a CAGR of 10.6% from 2024 to 2030.
Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.
The Implantable Neurostimulation Devices market is primarily driven by the rising prevalence of neurological disorders such as Parkinson's disease, epilepsy, chronic pain, and depression. As the global population ages, the incidence of these chronic conditions is increasing, creating a growing demand for effective and long-term treatment options. Implantable neurostimulators offer a promising solution for managing symptoms of these conditions, particularly for patients who have not responded to conventional therapies. Technological advancements in neurostimulation devices, such as more refined targeting mechanisms, smaller device sizes, and enhanced patient control, are also fueling market growth by improving treatment outcomes and patient satisfaction.
However, the market faces several challenges, including the high cost of implantable devices and the associated surgical procedures. These costs can limit accessibility, especially in low- and middle-income countries or healthcare systems with budget constraints. Additionally, while neurostimulators have shown positive results in treating various conditions, concerns remain regarding the long-term effectiveness, potential side effects, and device-related complications, such as battery life and the need for device replacements. The complexity of implantation and post-operative care also presents challenges for healthcare providers, requiring specialized training and resources, which may hinder broader adoption.
North America is the largest sales region of implantable neurostimulation devices, with market share nearly 42% in 2023. Europe is the second largest sales of implantable neurostimulation devices, enjoying market share nearly 29% in 2023. Medtronic, Boston Scientific, Abbott, LivaNova are the leading company, with the market share about 90%.
LP Information, Inc. (LPI) ' newest research report, the “Implantable Neurostimulation Devices Industry Forecast” looks at past sales and reviews total world Implantable Neurostimulation Devices sales in 2023, providing a comprehensive analysis by region and market sector of projected Implantable Neurostimulation Devices sales for 2024 through 2030. With Implantable Neurostimulation Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Implantable Neurostimulation Devices industry.
This Insight Report provides a comprehensive analysis of the global Implantable Neurostimulation Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Implantable Neurostimulation Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Implantable Neurostimulation Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Implantable Neurostimulation Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Implantable Neurostimulation Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Implantable Neurostimulation Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Others
Segmentation by Application:
Parkinson’s Disease
Epilepsy
Pain Management
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Boston Scientific
Abbott
LivaNova
Nevro
Ruishenan Medical
Beijing Pins
Sceneray
Inspire Medical Systems
Nurotron
Key Questions Addressed in this Report
What is the 10-year outlook for the global Implantable Neurostimulation Devices market?
What factors are driving Implantable Neurostimulation Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Implantable Neurostimulation Devices market opportunities vary by end market size?
How does Implantable Neurostimulation Devices break out by Type, by Application?